The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer
Abstract
BACKGROUND: Experimental studies in animals and observational studies in humans suggest that regular aspirin use may decrease the risk of colorectal adenomas, the precursors to most colorectal cancers. METHODS: We conducted a randomized, double-blind trial to determine the effect of aspirin on the incidence of colorectal adenomas. We randomly assigned 635 patients with previous colorectal cancer to receive either 325 mg of aspirin per day or placebo. We determined the proportion of patients with adenomas, the number of recurrent adenomas, and the time to the development of adenoma between randomization and subsequent colonoscopic examinations. Relative risks were adjusted for age, sex, cancer stage, the number of colonoscopic examinations, and the time to a first colonoscopy. The study was terminated early by an independent data and safety monitoring board when statistically significant results were reported during a planned interim analysis. RESULTS: A total of 517 randomized patients had at least one colonoscopic examination a median of 12.8 months after randomization. One or more adenomas were found in 17 percent of patients in the aspirin group and 27 percent of patients in the placebo group (P=0.004). The mean (+/-SD) number of adenomas was lower in the aspirin group than the placebo group (0.30+/-0.87 vs. 0.49+/-0.99, P=0.003 by the Wilcoxon test). The adjusted relative risk of any recurrent adenoma in the aspirin group, as compared with the placebo group, was 0.65 (95 percent confidence interval, 0.46 to 0.91). The time to the detection of a first adenoma was longer in the aspirin group than in the placebo group (hazard ratio for the detection of a new polyp, 0.64; 95 percent confidence interval, 0.43 to 0.94; P=0.022). CONCLUSIONS: Daily use of aspirin is associated with a significant reduction in the incidence of colorectal adenomas in patients with previous colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Generalized Linear Models (2nd ed.).
Therneau, T. M., McCullagh, P., & Nelder, J. A. (1993) · Journal of the American Statistical Association · doi:10.2307/2290358 · Cited by 4,907
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Self-citationTreatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis
Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., & Offerhaus, G. J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281805 · Cited by 1,717
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
Colorectal cancer screening: Clinical guidelines and rationale
Winawer, S., Fletcher, R., Miller, L., Godlee, F., Stolar, M., Mulrow, C., Woolf, S., Glick, S., Ganiats, T., Bond, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.agast970594 · Cited by 1,612
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021735 · Cited by 1,416
Self-citationAspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,090
Lack of Effect of a Low-Fat, High-Fiber Diet on the Recurrence of Colorectal Adenomas
Schatzkin, A., Lanza, E., Corle, D., Lance, P., Iber, F., Caan, B., Shike, M., Weissfeld, J., Burt, R., Cooper, M. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421601 · Cited by 931
Calcium Supplements for the Prevention of Colorectal Adenomas
Baron, J. A., Beach, M., Mandel, J. S., van Stolk, R. U., Haile, R. W., Sandler, R. S., Rothstein, R., Summers, R. W., Snover, D. C., Beck, G. J., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400204 · Cited by 865
Self-citationLack of Effect of a High-Fiber Cereal Supplement on the Recurrence of Colorectal Adenomas
Alberts, D. S., Martínez, M. E., Roe, D. J., Guillén-Rodríguez, J. M., Marshall, J. R., van Leeuwen, J. B., Reid, M. E., Ritenbaugh, C., Vargas, P. A., Bhattacharyya, A. B., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421602 · Cited by 826
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00001 · Cited by 785
A Clinical Trial of Antioxidant Vitamins to Prevent Colorectal Adenoma
Greenberg, E. R., Baron, J. A., Tosteson, T. D., Freeman, D. H., Beck, G. J., Bond, J. H., Colacchio, T. A., Coller, J. A., Frankl, H. D., Haile, R. W., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407213310301 · Cited by 762
Self-citationAspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study
Schreinemachers, D. M., & Everson, R. B. (1994) · Epidemiology · doi:10.1097/00001648-199403000-00003 · Cited by 736
Sulindac causes regression of rectal polyps in familial adenomatous polyposis
Labayle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Duhamel, O., Trousset, M., & Attali, P. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90519-q · Cited by 719
Kune, G. A., Kune, S., & Watson, L. F. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym193 · Cited by 654
A Hypothesis: Nonsteroidal Anti-Inflammatory Drugs Reduce the Incidence of Large-Bowel Cancer
Rosenberg, L., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Stolley, P. D., & Shapiro, S. (1991) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/83.5.355 · Cited by 501
Chemoprevention of Colorectal Cancer
Jänne, P. A., & Mayer, R. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422606 · Cited by 496
Aspirin use and chronic diseases: a cohort study of the elderly.
Paganini-Hill, A., Chao, A., Ross, R. K., & Henderson, B. E. (1989) · BMJ · doi:10.1136/bmj.299.6710.1247 · Cited by 396
O’Shaughnessy, J., Kelloff, G. J., Gordon, G., Dannenberg, A. J., Hong, W. K., Fabian, C. J., Sigman, C. C., Bertagnolli, M. M., Stratton, S. P., Lam, S. C., et al. (2002) · PubMed · Cited by 383
García Rodríguez, L. A., & Huerta-Alvarez, C. (2001) · Epidemiology · doi:10.1097/00001648-200101000-00015 · Cited by 359
Randomized Trial of Intake of Fat, Fiber, and Beta Carotene to Prevent Colorectal Adenomas
MacLennan, R., Macrae, F., Bain, C., Battistutta, D., Chapuis, P., Gratten, H., Lambert, J., Newland, R. C., Ngu, M., Russell, A., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.23.1760 · Cited by 333
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
Xu, X.-M., Sansores-Garcia, L., Chen, X.-M., Matijevic-Aleksic, N., Du, M., & Wu, K. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5292 · Cited by 301
Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study
Sturmer, T., Glynn, R. J., Lee, I.-M., Manson, J. E., Buring, J. E., & Hennekens, C. H. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-9-199805010-00003 · Cited by 294
Reduced Risk of Large-Bowel Adenomas Among Aspirin Users
Greenberg, E. R., Baron, J. A., D. H., F., Mandel, J. S., & Haile, R. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.11.912 · Cited by 293
Self-citationAspirin use, cancer, and polyps of the large bowel
Suh, O., Mettlin, C., & Petrelli, N. J. (1993) · Cancer · doi:10.1002/1097-0142(19930815)72:4<1171::aid-cncr2820720407>3.0.co;2-d · Cited by 276
Self-citationLogan, R. F., Little, J., Hawtin, P. G., & Hardcastle, J. D. (1993) · BMJ · doi:10.1136/bmj.307.6899.285 · Cited by 264
Smalley, W., Ray, W. A., Daugherty, J., & Griffin, M. R. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.2.161 · Cited by 264
Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study
Cruz–Correa, M., Hylind, L. M., Romans, K. E., Booker, S. V., & Giardiello, F. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.31890 · Cited by 245
Aspirin and Nonsteroidal Anti-inflammatory Drug Use and the Risk of Subsequent Colorectal Cancer
Peleg, I. I. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.4.394 · Cited by 213
Nonsteroidal antiinflammatory drugs and colorectal cancer
Muscat, J. E., Stellman, S. D., & Wynder, E. L. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7<1847::aid-cncr2820740704>3.0.co;2-# · Cited by 197
A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps
McKeown-Eyssen, G. E., Bright-See, E., Robert Bruce, W., & Jazmaji, V. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90299-2 · Cited by 184
Green, R. J., Metlay, J. P., Propert, K., Catalano, P. J., Macdonald, J. S., Mayer, R. J., & Haller, D. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-4-200202190-00005 · Cited by 161
Practical problems in interim analyses, with particular regard to estimation
Pocock, S. J., & Hughes, M. D. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90059-7 · Cited by 160
Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing
Collet, J., Sharpe, C., Belzile, É., Boivin, J. ‐., Hanley, J. A., & Abenhaim, L. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690651 · Cited by 152
Ladabaum, U., Chopra, C., Huang, G., Scheiman, J., Chernew, M., & Fendrick, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00007 · Cited by 138
Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas
Sandler, R. S., Galanko, J. C., Murray, S. C., Helm, J. F., & Woosley, J. T. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70526-8 · Cited by 122
Self-citationVecchia, C. L., Negri, E., Franceschi, S., Conti, E., Montella, M., Giacosa, A., Falcini, F., & Decarli, A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.444 · Cited by 97
Martínez, M. E., McPherson, R. S., Levin, B., & Annegers, J. F. (1996) · PubMed · Cited by 86
Chemoprevention of colorectal cancer by aspirin: A cost-effectiveness analysis
Suleiman, S., Rex, D. K., & Sonnenberg, A. (2002) · Gastroenterology · doi:10.1053/gast.2002.29689 · Cited by 70
Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs
Shaheen, N. J., Straus, W. L., & Sandler, R. S. (2002) · Cancer · doi:10.1002/cncr.10333 · Cited by 63
Self-citationSample, D., Wargovich, M. J., Fischer, S. M., Inamdar, N., Schwartz, P. E., Wang, X., Do, K.-A., & Sinicrope, F. A. (2002) · PubMed · Cited by 53
Cited by
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021735 · Cited by 1,416
Self-citationRothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., García Rodríguez, L. A., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,218
Metadata
- Authors
- Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., Steinbach, G., & Schilsky, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-03-06
- Volume
- 348
- Issue
- 10
- Pages
- 883-890
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1975076018
- Cited by
- 1,136
- References
- 45
- FWCI
- 62.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.